secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lunai Bioworks Inc. (LNAI)
CIK:        0001527728
Form:       8-K
Filed at:   2025-04-10T23:59:59+00:00
Accession:  0001731122-25-000562
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.70
Item codes: 3.02, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Renovaro completes acquisition of Biosymetrics, issues 15M shares
-----------------------------------------------------------------

- Consummated merger with Biosymetrics on April 8, 2025; Biosymetrics becomes wholly owned subsidiary.
- Issued 15.0 million shares of Renovaro common stock to former Biosymetrics stockholders.
- Shares issued in reliance on Section 4(a)(2) exemption based on accredited investor representations.
- Transaction was previously announced on February 26, 2025 via Merger Agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1527728/000173112225000562/0001731122-25-000562-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1527728/000173112225000562/e6512_8k.htm
  HTML page:      https://secwatch.observer/filing/0001731122-25-000562

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer